Chemical Compound
Tafenoquine succinate
CAS Registry Number
106635-81-8
Primary Record
Tafenoquine succinate
Note: Only for scientific research or as raw materials for production.
- In stock
- 4,090 g
- Purity
- 98.4 %
- CAS
- 106635-81-8
Compound Identifiers & Properties
- CAS
- 106635-81-8
- PubChem CID
- 163761
- SMILES
- CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC.C(CC(=O)O)C(=O)O
- Canonical SMILES
- COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1.O=C(O)CCC(=O)O
Names & Synonyms
- Tafenoquine succinate
- Tafenoquine
- Etaquine
- Krintafel
- Arakoda
- 106635-81-8
- WR238605 succinate
- tafenoquine maleate
- Krintafel (TN)
- Tafenoquine (Succinate)
- Arakoda (TN)
- DL5J0B8VSS
- WR-238605
- UNII-DL5J0B8VSS
- RefChem:57196
- Tafenoquine succinate [USAN]
- AC1L4TJS
- WR 238605 Succinate
- MLS006010680
- Tafenoquine succinate (USAN)
- DTXSID10910065
- CQBKFGJRAOXYIP-UHFFFAOYSA-N
- SB-252263-AX
- orb1309033
- SCHEMBL1004186
- 106635-81-8 (succinate)
- CHEMBL2364635
- SCHEMBL29758301
- WR 238605
- C28H34F3N3O7
- MFCD00892249
- C24H28F3N3O3.C4H6O4
- DTXCID301339122
- SB252263AX
- TAFENOQUINE SUCCINATE [MI]
- SB-252263AX
- SB252263-AX
- CID163761
- EBC-99065
- AKOS037648507
- TAFENOQUINE SUCCINATE [WHO-DD]
- HY-111529A
- Tafenoquine succinate, >=95% (HPLC)
- BS-14295
- DA-58245
- LS-45733
- SMR004701662
- SY248282
- TAFENOQUINE SUCCINATE [ORANGE BOOK]
- SB-252263
- CS-0083862
- C24-H28-F3-N3-O3.C4-H6-O4
- D10670
- D80913
- A904698
- Q27276464
- N4-(2,6-Dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine succinate(1:1)
- B2692-334165
- Butanedioic acid, compd. with N(sup 4)-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
- butanedioic acid;4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine
- 106635-80-7
- Butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
- Butanedioic acid, compd. with N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-1,4-pentanediamine (1:1)
- N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine succinate
- (4RS)-N4-{2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl}pentane-1,4-diamine butanedioate
- 8-[(4-amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinoline succinate
- Butanedioic acid, compd. with N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-1,4-pentanediamine (1:1); 1,4-Pentanediamine, N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-, butanedioate (1:1) (9CI); 8-[(4-Amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline succinate; SB 252263; SB 252263AX; Tafenoquine succinate; WR 238605 succinate; SB-252263-AX
- Butanedioic acid--N~4~-{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl}pentane-1,4-diamine (1/1)
- butanedioic acid; 4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine
- N4-(2,6-Dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diaminesuccinate(1:1)
- N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolyl]pentane-1,4-diamine;succinic acid